Should You Buy Figma Stock After Its 59% Drop Since August?

Figma (NYSE: FIG) shares have plummeted 59% from their post-IPO peak, significantly underperforming the S&P 500, primarily due to decelerating revenue growth and an unsustainable valuation. The company reported Q2 2025 revenue growth of 41% year-over-year, a slowdown from Q1's 46%, and guided for further deceleration to 33% in Q3 and an implied 30% in Q4, disappointing investors who had initially valued the stock at over 66 times sales. Despite high market penetration, future growth is challenged by limited new customer acquisition and upsell opportunities, with much of its projected growth attributed to a recent 20%+ price increase, maintaining valuation risk even after the substantial decline.

Analysis

Figma's (NYSE: FIG) stock has undergone a significant price correction, falling 59% from its post-IPO peak, due to a fundamental reassessment of its valuation against a backdrop of decelerating growth. The company's first public earnings report revealed a slowdown in year-over-year revenue growth from 46% in Q1 to 41% in Q2 2025, with management guidance indicating a further deceleration to 33% in Q3 and an implied 30% for Q4. This trajectory undermines the initial valuation which peaked at over 66 times sales. Even after the steep sell-off, the stock trades at over 30 times sales, a multiple considered rich for a firm with a declining growth rate. The slowdown is contextualized by the company's high market penetration, with 78% of the Forbes 2000 already as customers, limiting the potential for new large-scale client acquisition. Furthermore, much of the projected 2025 growth is attributed to a recent price increase of over 20%, a lever that is not sustainably repeatable and introduces potential customer churn risk. While the company holds a strong cash position of $1.6 billion for potential acquisitions or R&D, the current outlook suggests significant headwinds to organic growth.

Key Decisions for Investors

• Given the stock still trades at a high multiple of over 30 times sales, investors should be cautious as the valuation may not have fully priced in the decelerating revenue growth projected to fall to 30% by Q4.
• Investors should scrutinize future earnings reports for signs of growth stabilization or re-acceleration that is not primarily dependent on price increases, as the current model reliant on price hikes is not a sustainable long-term strategy.
• Monitor the company's deployment of its $1.6 billion cash reserve for strategic acquisitions or meaningful R&D developments, as these are the most likely catalysts to offset the maturation of its core market.
• Considering the pronounced post-IPO volatility and overwhelmingly negative sentiment, a neutral or underweight position may be prudent until the market finds a stable valuation floor for the company's revised growth profile.